Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma

doi:10.3748/wjg.v27.i2.189

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9053)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-5) series.

Item

Count

PDF

501

WORD

286

HTML

4039

Figures (1-6)

602

Tables (1-5)

324

Sum=5752

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

397

Download

904

Sum=1301

Publishing Process of This Article

Item

Count

Browse

514

Download

1486

Sum=2000

Jan 14, 2021 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jan 14, 2021; 27(2): 189-207
Published online Jan 14, 2021. doi: 10.3748/wjg.v27.i2.189

Full Size Figure Download Figure

Figure 1 Flowchart for inclusion and exclusion of patients within the training and validation cohort. TACE: Transarterial chemoembolization; ECOG: Eastern Cooperative Oncology Group; BCLC: Barcelona Clinic Liver Cancer; CT: Computed tomography; HCC: Hepatocellular carcinoma.

Citation: Niu XK, He XF. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma. World J Gastroenterol 2021; 27(2): 189-207
URL: https://www.wjgnet.com/1007-9327/full/v27/i2/189.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i2.189